Parker Institute for Cancer Immunotherapy:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Parker Institute for Cancer Immunotherapy - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9390
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Parker Institute for Cancer Immunotherapy (Parker Institute), a subsidiary of The Parker Foundation is a nonprofit public benefit corporation which focuses on the development of immune therapies for the treatment of cancer. The institute coordinates together the scientists, nonprofits, academic institutions, biotechnology, and pharmaceutical industry partners to provide innovative services, tools and resources for new discoveries in cancer immunotherapy research. Its research focuses in the areas of T-cell therapies, tumor antigen discovery, tumor microenvironment and checkpoint blockade response. The institute works in collaboration with other research centers such as Memorial Sloan Kettering Cancer Center, Washington University School of Medicine, The University of Pennsylvania, Dana-Farber Cancer Institute, Stanford Medicine, and others. Parker Institute is headquartered in San Francisco, California, the US.

Parker Institute for Cancer Immunotherapy – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Parker Institute for Cancer Immunotherapy, Medical Devices Deals, 2012 to YTD 2018 9
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Tmunity Therapeutics Raises Additional USD35 Million in Series A Venture Financing 12
Tmunity Therapeutics Raises USD100 Million in Series A Venture Financing 14
ImaginAb Raises USD7.7 Million in Venture Financing 16
Partnerships 17
Parker Institute for Cancer Immunotherapy Enters into Partnership with Xyphos Biosciences 17
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 18
Seres Therapeutics to Enter into Partnership Agreement with MD Anderson and Parker Institute 19
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 20
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and Cancer Research Institute Enter into Research Partnership 21
Parker Institute for Cancer Immunotherapy Enters into Agreement with PsiOxus Therapeutics 22
Parker Institute for Cancer Immunotherapy – Key Employees 23
Parker Institute for Cancer Immunotherapy – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Government and Public Interest 25
May 15, 2018: Penn Study Finds that Different Diseases Elicit Distinct Sets of Exhausted T Cells 25
Product News 26
Apr 10, 2017: Parker Institute researchers publish first major scientific paper in Nature 26
Mar 07, 2018: Parker Institute for Cancer Immunotherapy: The battle to tame autoimmunity 27
Mar 05, 2018: Predicting Childhood Leukemia Relapse Using Machine Learning 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Key Facts 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Parker Institute for Cancer Immunotherapy, Deals By Therapy Area, 2012 to YTD 2018 8
Parker Institute for Cancer Immunotherapy, Medical Devices Deals, 2012 to YTD 2018 9
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tmunity Therapeutics Raises Additional USD35 Million in Series A Venture Financing 12
Tmunity Therapeutics Raises USD100 Million in Series A Venture Financing 14
ImaginAb Raises USD7.7 Million in Venture Financing 16
Parker Institute for Cancer Immunotherapy Enters into Partnership with Xyphos Biosciences 17
Inovio Pharma and Parker Institute for Cancer Immunotherapy Enter into Agreement 18
Seres Therapeutics to Enter into Partnership Agreement with MD Anderson and Parker Institute 19
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Agreement 20
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and Cancer Research Institute Enter into Research Partnership 21
Parker Institute for Cancer Immunotherapy Enters into Agreement with PsiOxus Therapeutics 22
Parker Institute for Cancer Immunotherapy, Key Employees 23

List of Figures
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Parker Institute for Cancer Immunotherapy, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Parker Institute for Cancer Immunotherapy, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Parker Institute for Cancer Immunotherapy:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Constellation Brands, Inc.:戦略・SWOT・企業財務分析
    Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DTEK Energy BV:企業の戦略的SWOT分析
    DTEK Energy BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Jiuzhitang Co Ltd (000989):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiuzhitang Co Ltd (Jiuzhitang), formerly Labor Jiuzhitang Pharmacy, is a Chinese medicine manufacturing company. The company offers products such as shuxuetong injection, lujiao granule, liuwei dihuang wan pills, zuguang power, siqikang injection, luo hua zi zhu tablets, compound jiangzhi ta …
  • Bechtel Corporation:電力:M&Aディール及び事業提携情報
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, infrastructure, communications, mining and metals, oil and gas, chemicals, water, defense and nuclear, and governme …
  • Theravance Biopharma Inc (TBPH):企業の財務・戦略的SWOT分析
    Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia) is an agricultural and clean technology company that develops and commercializes agricultural products. Its major products include goodwheat branded ingredients, nutritional oils, animal nutrition and agricultural products. The company's products exhibit tra …
  • KrisEnergy Holdings Ltd (SK3):企業の財務・戦略的SWOT分析
    Summary KrisEnergy Holdings Ltd (KrisEnergy) is an independent upstream company that production and development of oil and gas in the basins. The company discovers, appraises, develops and produces hydrocarbon resources. It services comprise development and production of identifying potential prospe …
  • Japan Tobacco Inc (2914):製薬・医療:M&Aディール及び事業提携情報
    Summary Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes. It also manufactures, markets and sells varied pharmaceutical and processed food products such as frozen cooked rice and noodles, instant noodles, bread and frozen bread, mineral water, and seasoning, p …
  • NetScout Systems, Inc. (NTCT):企業の財務・戦略的SWOT分析
    NetScout Systems, Inc. (NTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Philips Healthcare-製薬・医療分野:企業M&A・提携分析
    Summary Philips Healthcare, formerly Philips Medical Systems, undertakes the manufacture and distribution of diagnostic imaging systems, healthcare information technology solutions, patient monitoring and cardiac devices. Philips Healthcare is a division of Royal Philips Electronics of the Netherlan …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析
    Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Metlifecare Ltd (MET)-製薬・医療分野:企業M&A・提携分析
    Summary Metlifecare Ltd (Metlifecare) is a healthcare service provider that owns and manages retirement villages to older citizens in New Zealand. The center provides retirement villages provide services such as healthcare services, security, community and companionship, maintenance free living and …
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Legal & General Group Plc:企業のM&A・事業提携・投資動向
    Legal & General Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Legal & General Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Strategic Resources Inc. (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc. (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Karambunai Corporation Berhad:戦略・SWOT・企業財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Neovasc Inc (NVC):企業の財務・戦略的SWOT分析
    Summary Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is design …
  • Ultra Electronics Holdings Plc:企業の戦略・SWOT・財務情報
    Ultra Electronics Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Ultra Electronics Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Trianni Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trianni Inc (Trianni) is a developer of fully human monoclonal antibodies that provides its propriety discovery platform. The company provides Trianni Mouse platform that holds engineered versions of three antibody-encoding genetic loci, namely, Heavy, Kappa, Lambda, and others. It enables t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆